Alzheimer-related τ-pathology in the perforant path target zone and in the hippocampal stratum oriens and radiatum correlates with onset and degree of dementia

Experimental Neurology

Volumn 163, Issue 1, 2000, Pages 98-110

  Thal, Dietmar Rudolf ^a,b   Holzer, Max ^a   Rüb, Udo ^b   Waldmann, Guido ^a   Günzel, Steffen ^a   Zedlick, Dyrk ^a   Schober, Ralf ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

Alzheimer's disease; Clinical dementia rating; Hippocampus; Perforant path; PHF ; Staging

Indexed keywords

TAU PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; AMYLOIDOSIS; ARTICLE; DEMENTIA; DIAGNOSTIC VALUE; DISEASE SEVERITY; HIPPOCAMPUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; NEUROPATHOLOGY; NEUROPIL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RATING SCALE;

EID: 0034070445     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.2000.7380     Document Type: Article

References (66)

1. Alford M. F., Masliah E., Hansen L. A., Terry R. D. A simple dot immunobinding assay for quantification of synaptophysin-like immunoreactivity in human brain. J. Histochem. Cytochem. 42:1994;283-287.
2. Alonso A. D. C., Gundke-Iqbal I., Iqbal K. Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules. Nature Med. 2:1996;783-787.
3. Amaral D. G., Ishizuka N., Claiborne B. Neurons, numbers and the hippocampal network. Storm-Mathisen J., Zimmer J., Ottersen O. P. Progress in Brain Research. 1990;1-11 Elsevier, Amsterdam.
4. Arendt T., Bigl V., Arendt A., Tennstedt A. Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease, paralysis agitans and Korsakoff's disease. Acta Neuropathol. 61:1983;101-108.
5. Arriagada P. V., Marzloff K., Hyman B. T. Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease. Neurology. 42:1992;1681-1688.
6. Allsop D., Landon M., Kidd M., Lowe J. S., Reynolds G. P., Gardner A. Monoclonal antibodies raised against a subsequence of senile plaque core protein react with plaque cores, plaque periphery and cerebrovascular amyloid in Alzheimer's disease. Neurosci. Lett. 68:1986;252-266.
7. Bancher C., Brunner C., Lassmann H., Budka H., Jellinger K., Wiche G., Seitelberger F., Grundke-Iqbal I., Wisniewski H. M. Accumulation of abnormally phosphorylated τ precedes the formation of neurofibrillary tangles in Alzheimer's disease. Brain Res. 477:1989;90-99.
8. Bancher C., Braak H., Fischer P., Jellinger K. A. Neuropathological staging of Alzheimer lesions and intellectual status in Alzheimer's and Parkinson's disease patients. Neurosci. Lett. 162:1993;179-182.
9. Bancher C., Jellinger K., Lassmann H., Fischer P., Leblhuber F. Correlation between mental state and quantitative neuropathology in the Vienna longitudinal study on dementia. Eur. Arch. Psychiatry. Clin. Neurosci. 246:1996;137-146.
10. Bannerman D. M., Good M. A., Butcher S. P., Ramsay M., Morris R. G. M. Distinct components of spatial learning revealed by prior training and NMDA receptor blockade. Nature. 378:1995;182-186.
11. Barnes C. A. Effects of aging on the dynamics of information processing and synaptic weight changes in the mammalian hippocampus. Coleman P., Higgins G., Phelps C. Progress in Brain Research. 1990;89-104 Elsevier, Amsterdam.
12. Bobinski M., Wegiel J., Tarnawski M., Bobinski M., Reisberg B., de Leon M. J., Miller D. C., Wisniewski H. M. Relationships between regional neuronal loss and neurofibrillary changes in the hippocampal formation and duration and severity of Alzheimer disease. J. Neuropathol. Exp. Neurol. 56:1997;414-420.
13. Braak E., Braak H., Mandelkow E.-M. A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads. Acta Neuropathol. 87:1994;554-567.
14. Braak H., Braak E., Grundke-Iqbal I., Iqbal K. Occurrence of neuropil threads in the senile human brain and in Alzheimer's disease: A third location of paired helical filaments outside of neurofibrillary tangles and neuritic plaques. Neurosci. Lett. 65:1986;351-355.
15. Braak H., Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82:1991;239-259.
16. Braak H., Braak E. The human entorhinal cortex: Normal morphology and lamina-specific pathology in various diseases. Neurosci. Res. 15:1992;6-31.
17. Braak H., Braak E. Staging of Alzheimer's disease-related neurofibrillary changes. Neurobiol. Aging. 16:1995;271-284.
18. Braak H., Braak E., Bohl J., Reintjes J. Age, neurofibrillary changes, Aβ-amyloid and the onset of Alzheimer's disease. Neurosci. Lett. 210:1996;87-90.
19. Braak H., Braak E. Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol. Aging. 18:1997;351-357.
20. Brion J.-P., Tremp G., Octave J.-N. Transgenic expression of the shortest human tau affects its compartmentalization and its phosphorylation as in the pretangle stage of Alzheimer's disease. Am. J. Pathol. 154:1999;255-270.
21. Brückner M., Bendix U., Hube M., Arendt T., Bigl V. Alzheimer's disease: A monoclonal antibody raised against paired helical filaments. Acta Histochem. 41:1992;143-152.
22. Buzsáki G., Chen L. S., Gage F. H. Spatial organization of physiological activity in the hippocampal region: Relevance to memory formation. Storm-Mathisen J., Zimmer J., Ottersen O. P. Progress in Brain Research. 1990;257-268 Elsevier, Amsterdam.
23. Cummings B. J., Cotman C. W. Image analysis of beta-amyloid load in Alzheimer's disease and relation to dementia. Lancet. 346:1995;1524-1528.
24. DeKosky S. T., Scheff S. W. Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity. Ann. Neurol. 27:1990;457-464.
25. Dickson D. W., Ksiezak-Reding H., Liu W. K., Davies P., Crowe A., Yen S.-H. C. Immunocytochemistry of neurofibrillary tangles with antibodies to subregions of tau protein: Identification of hidden and cleaved tau epitopes and a new phosphorylation site. Acta Neuropathol. 84:1992;596-605.
26. Dickson D. W., Crystal H. A., Bevona C., Honer W., Vincent I., Davies P. Correlations of synaptic and pathological markers with cognition of the elderly. Neurobiol. Aging. 16:1995;285-304.
27. Geula C. Abnormalities of neural circuitry in Alzheimer's disease: Hippocampus and cortical cholinergic innervation. Neurology. 51:1998;S18-S29.
28. Goedert M., Spillantini M. G., Jakes R., Rutherford D., Crowther R. A. Multiple isoforms of human microtubule-associated protein tau: Sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron. 3:1989;519-526.
29. Goedert M., Jakes R., Vanmechelen E. Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205. Neurosci. Lett. 189:1995;167-169.
30. Gomez-Isla T., Price J. L., McKeel D. W. Jr., Morris J. C., Growdon J. H., Hyman B. T. Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. J. Neurosci. 16:1996;4491-4500.
31. Greenberg S. G., Davies P. A preparation of Alzheimer paired helical filaments that display distinct tau proteins by polyacrylamide gel electrophoresis. Proc. Natl. Acad. Sci. USA. 87:1990;5827-5831.
32. Hardy J. Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci. 20:1997;154-159.
33. Henderson Z., Harrison P. S., Jagger E., Beeby J. H. Density of choline acetyltransferase-immunoreactive terminals in the rat dentate gyrus after entorhinal cortex lesions: A quantitative light microscopic study. Exp. Neurol. 152:1998;50-63.
34. Holzer M., Holzapfel H.-P., Zedlick D., Brückner M. K., Arendt T. Abnormally phosphorylated tau protein in Alzheimer's disease: Heterogeneity of individual regional distribution and relationship to clinical severity. Neuroscience. 63:1994;499-516.
35. Hughes C. P., Berg L., Danziger W. L., Coben L. A., Martin R. L. A new clinical scale for the staging of dementia. Br. J. Psychiat. 140:1982;566-572.
36. Hyman B. T., Van Hoesen G. W., Kromer L. J., Damasio A. R. Perforant pathway changes and the memory impairment of Alzheimer's disease. Ann. Neurol. 20:1986;472-481.
37. Hyman B. T., Kromer L. J., Van Hoesen G. W. A direct demonstration of the perforant pathway terminal zone in Alzheimer's disease using the monoclonal antibody Alz-50. Brain Res. 450:1988;392-397.
38. Hyman B. T., Damasio H., Damasio A. R., Van Hoesen G. W. Alzheimer's disease. Annu. Rev. Pub. Health. 10:1989;115-140.
39. Hyman B. T., West H. L., Gomez-Isla T., Mui S. Quantitative neuropathology in Alzheimer's disease: Neuronal loss in high-order association cortex parallels dementia. Iqbal K., Mortimer J. A., Winblad B., Wisniewski H. M. Research Advances in Alzheimer's Disease and Related Disorders. 1995;453-460 Wiley, New York.
40. Jones R. S. G. Entorhinal hippocampal connections: A speculative view of their function. Trends Neurosci. 16:1993;58-64.
41. Kosik K. S. The molecular and cellular biology of tau. Brain Pathol. 3:1993;39-43.
42. Kosik K. S., Joachim C. L., Selkoe D. J. Microtubule associated protein tau (τ) is a major antigenic component of paired helical filaments in Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 83:1986;4044-4048.
43. Mandelkow E.-M., Biernat J., Drewes G., Steiner B., Lichtenberg-Kraag B., Wille H., Gustke N., Mandelkow E. Microtubule-associated protein tau, paired helical filaments, and phosphorylation. Ann. N. Y. Acad. Sci. 695:1993;209-216.
44. Matthews D. A., Cotman C., Lynch G. An electron microscopic study of lesion-induced synaptogenesis in the dentate gyrus of the adult rat. I. Magnitude and time course of degeneration. Brain Res. 115:1976;1-21.
45. McKeith I. G., Galasko D., Kosaka K., Perry E. K., Dickson D. W., Hansen L. A., Salmon D. P., Lowe J., Mirra S. S., Byrne E. J., Lennox G., Quinn N. P., Edwardson J. A., Ince P. G., Bergeron C., Burns A., Miller B. L., Lovestone S., Collerton D., Jansen E. N. H., Ballard C., de Vos R. A. I., Wilcock G. K., Jellinger K. A., Perry R. H. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop. Neurology. 47:1996;1113-1124.
46. Nagy Zs., Yilmazer-Hanke D. M., Braak H., Braak E., Schultz C., Hanke J. Assessment of the pathological stages of Alzheimer's disease in thin paraffin sections: A comparative study. Dement. Geriatr. Cogn. Disord. 9:1998;140-144.
47. Nukina N., Ihara Y. One of the antigenic determinants of paired helical filaments is related to tau protein. J. Biochem. 99:1986;1541-1544.
48. Saucier D., Cain D. P. Spatial learning without NMDA receptor-dependent long-term potentiation. Nature. 378:1995;186-189.
49. Scheuner D., Eckman C., Jensen M., Song X., Citron M., Suzuki N., Bird T. D., Hardy J., Hutton M., Kukull W., Larson E., Levy-Lahad E., Vitanen M., Peskind E., Poorkaj P., Schellenberg G., Tanzi R., Wasco W., Lannfelt L., Selkoe D., Younkin S. Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nature Med. 2:1996;864-870.
50. Schlander M., Frotscher M. Non-pyramidal neurons in the guinea pig hippocampus: A combined Golgi-electron microscope study. Anat. Embryol. 174:1986;35-47.
51. Schwartzkroin P. A., Scharfman H. E., Sloviter R. S. Similarities in circuitry between Ammon's horn and dentate gyrus: Local interaction and parallel processing. Storm-Mathisen J., Zimmer J., Ottersen O. P. Progress in Brain Research. 1990;269-286 Elsevier, Amsterdam.
52. Solodkin A., van Hoesen G. W. Entorhinal cortex modules of the human brain. J. Comp. Neurol. 365:1996;610-627.
53. Su J. H., Deng G., Cotman C. W. Transneuronal degeneration in the spread of Alzheimer's disease pathology: Immunohistochemical evidence for transmission of tau hyperphosphorylation. Neurobiol. Dis. 4:1997;365-375.
54. Takeda A., Yasuda T., Miyata T., Mizuno K., Li M., Yoneyama S., Horie K., Maeda K., Sobue G. Immunohistochemical study of advanced glycation end products in aging and Alzheimer's disease brain. Neurosci. Lett. 221:1996;17-20.
55. Terry R. D., Masliah E., Salmon D. P., Butters N., DeTeresa R., Hill R., Hansen L. A., Katzman R. Physical basis of cognitive alterations in Alzheimer's disease: Synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 30:1991;572-580.
56. Thal D. R., Glas A., Schneider W., Schober R. Differential pattern of β-amyloid, amyloid precursor protein and apolipoprotein E expression in cortical senile plaques. Acta Neuropathol. 94:1997;255-265.
57. 2-macroglobulin and interleukin 6 in Alzheimer's disease. Brain Res. 777:1997;223-227.
58. Thal D. R., Arendt T., Waldmann G., Holzer M., Zedlick D., Rüb U., Schober R. Progression of neurofibrillary changes and PHF-τ in end stage Alzheimer's disease is different from cortical plaque and microglial pathology. Neurobiol. Aging. 19:1998;517-525.
59. Thal D. R., Schultz C., Rüb U., Braak E., Braak H. A constant sequence of Aβ-protein deposition within the human medial temporal lobe. Soc. Neurosci. Abstr. 25:1999.
60. Ulas J., Cotman C. W. Decreased expression of N-methyl-d-aspartate receptor 1 messenger RNA in select regions of Alzheimer brain. Neuroscience. 79:1997;973-982.
61. van Hoesen G. W., Solodkin A. Some modular features of temporal cortex in humans as revealed by pathological changes in Alzheimer's disease. Cereb. Cortex. 3:1993;465-475.
62. Wang J., Dickson D. W., Trojanowski J. Q., Lee V. M.-Y. The levels of soluble versus insoluble brain Aβ distinguish Alzheimer's disease from normal and pathologic aging. Exp. Neurol. 158:1999;328-337.
63. Wilcock G. Alzheimer's disease - A continuum of or contributed to by normal ageing? Alzheimer Res. 1:1995;61-65.
64. Witter M. P. Organization of the entorhinal-hippocampal system: A review of current anatomical data. Hippocampus. 3:1993;33-44.
65. Yan S. D., Yan S. F., Chen X., Fu J., Chen M., Kuppusamy P., Smith M. A., Perry G., Godman G. C., Nawroth P., Zweier J. L., Stern D. Non-enzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid β-peptide. Nature Med. 1:1995;693-699.
66. Yan S. D., Chen X., Fu J., Chen M., Zhu H., Roher A., Slattery T., Zhao L., Nagashima M., Morser J., Migheli A., Nawroth P., Stern D., Schmidt A. M. RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease. Nature. 382:1996;685-691.